Sunday, 25 December 2011

Mitsubishi Tanabe Pharma Corp.: PharmaVitae Profile

Datamonitor has identified 10 launch products in Mitsubishi Tanabe’s product portfolio, which are expected to provide $802m in sales growth out to 2016.

Features and benefits
• Gain insight into Mitsubishi Tanabe's strategic outlook across the next 6 years
• Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source

Request a Sample for or Inquire before buying the report @

This analysis examines the historical and forecast performance for Mitsubishi Tanabe in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

 Major points covered in Table of Contents of this report include:
• Tables and Figures

Explore Table of Contents available in the report Mitsubishi Tanabe Pharma Corp.: PharmaVitae Profile.

Friday, 23 December 2011

Global Transparent Caching Market

As communication service providers change their perception of online video from a traffic problem to a business opportunity, technologies like transparent caching will empower these service providers to capitalize on an ever growing source of revenue that is being woefully neglected right now. Transparent caching is expected to help spur the telecommunication industry to take charge of online video delivery in their own hands and help become content delivery networks in their own right. This study analyses the transparent caching market from a global perspective, includes a discussion of global drivers and restraints and competitive analysis.

Request a Sample for or Inquire before buying the report @

Table Of Contents
1. Executive Summary
Market Overview and Key Research Findings
Market Overview and Summary

2. Analysis of the Global Transparent Caching Market
Market Overview
Introduction and Market Definitions
Market Engineering Measurement Analysis
Drivers to Market Growth
Restraints to Market Growth
Market Forecasts and Trend Analysis
Market Forecasts
Product Pricing and Market Trends
Competitive Analysis
Competitive Structure and Market Landscape

Thursday, 22 December 2011

Health and Wellness in Germany

This Euromonitor market report provides market trend and market growth analysis of the Health and Wellness industry in Germany. With this market report, you’ll be able to explore in detail the changing shape and potential of the industry. You will now be able to plan and build strategy on real industry data and projections.

The Health and Wellness in Germany market research report includes:
• Analysis of key supply-side and demand trends
• Detailed segmentation of international and local products
• Historic volumes and values, company and brand market shares
• Five year forecasts of market trends and market growth
• Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:
• What is the market size of Health and Wellness in Germany?
• What are the major brands in Germany?
• Were the sales of health and wellness affected by the global recession?
• What functional ingredients in food and drinks are in fashion in Germany?
• Is the organic movement still growing?
• Are weight management food and drinks driven by product reformulation?

Request a Sample for or Inquire before buying the report @

Thursday, 15 December 2011

U.S. Government COTS IT Procurement Vehicles Market

The U.S. Government has a number of procurement vehicles for the commercial off the shelf (COTS) information technology that they buy on a routine basis. This market is experiencing a shift regarding the acquisition of products and services. Within the past few years, agency-specific contracts have garnered more attention from federal agencies due to key factors such as adaptability and lower pricing. Alleviating risks related to procurements is the overall key reason for federal agencies gravitating towards agency-specific contracts. With the General Services Administration (GSA) offering strategic partnering for those agencies, not only can procurement risks be mitigated, but monitoring of contracting activity increases significantly.

Table of Contents
U.S. Government COTS IT Procurement Vehicles Market
Title Slide
Research Team
Table of Contents

Executive Summary
Title Slide
Executive Summary
Market Engineering Measurements
CEO's Perspective

Browse All: Public Sector Market Research

Market Overview
Title Slide
Market Overview-History
Market Overview-Definitions
Key Questions


Wednesday, 14 December 2011

Asia Bottled Water 2011

An essential guide for soft drinks professionals worldwide, the Asia Bottled Water 2011 Report forms part of Canadean’s best selling series of global soft drinks reports.

Comprising of data tables and supporting text, the report provides information at a regional and country level. Data includes Bottled Water consumption (million litres & litres per capita) from 2005 to 2010, with forecasts to 2014. Percentage market shares are provided for segmentation data, packaging data and distribution (2009 and 2010 actuals, plus forecasts for 2011). Leading companies' market shares for 2009 and 2010 are provided. Asia Bottled Water Market valuation is provided for each country and, where applicable, new products in 2010 are identified. Supporting text includes commentary on current and emerging trends, segmentation, packaging, distribution, pricing/valuation and where applicable, functional drinks and private label.

Key information provided in this Report
• 14 individual country profiles and a regional overview
• Historic and forecast consumption data by region and by country (2005-2010 actuals plus forecasts to 2014)
• Segmentation data by country (Carbonated vs Still / Table vs Mineral/Spring)
• Key packaging data (Material / Non-Refillable vs Refillable / Multi Serve vs Single Serve) by country
• Distribution (on- vs off-premise) splits by country
• Leading companies' % market shares
• 2010 market valuation by country
• Market commentary including current and emerging trends

Monday, 12 December 2011

Packaged Food in Slovenia

Healthy value growth continues in packaged food in Slovenia during 2011
Packaged food in Slovenia is expected to have performed well during 2011, with positive growth projected across the majority of packaged food categories. However, when comparing growth rates from 2011 with growth from previous years of the review period, it is also clear that growth is slowing down in the majority of packaged food categories. This is mainly result of the residual effects of the global financial crisis, which is leading to Slovenian consumers thinking twice before parting with any amount of money, no matter how small. The ongoing high level of price sensitivity in Slovenia is leading many consumers to turn towards lower-priced packaged food, especially private label.

Browse All: Food Market Research Reports

Health and wellness and greater convenience remain the major trends
Two major trends had a significant impact on packaged food in Slovenia during 2010 and the first half of 2011. The first of these is the health and wellness trend, which remained the most influential trend in packaged food in Slovenia throughout the second half of the review period. As health awareness continues to rise among Slovenian consumers, demand for natural and healthier products is increasing. As a result of this, packaged food made using natural ingredients which offer additional benefits such as fortification with vitamins and calcium performed very well during 2010 and 2011, as did packaged food which contains less fat and fewer calories. Furthermore, packaged food which targets consumers with specific health needs also prospered during 2010 and 2011. The second important trend influencing packaged food in Slovenia during the second half of the review period was the rising demand for greater convenience. This arose as a result of Slovenians having less spare time than ever, leading them to demand packaged food which can be prepared and consumed quickly and easily.

The predominance of domestic producers is set to continue
Slovenian consumers generally prefer domestic packaged food brands and products and this has resulted in domestic producers dominating packaged food for some time. Artisanal bakeries and Ljubljanske Mlekarne dd are the leading players in overall Slovenia packaged food industry. These are all domestic producers and a similar picture also becomes apparent when looking at the company rankings within specific categories. In the majority of packaged food categories, the leading producers are all domestic companies. Nevertheless, the influence of multinational companies remains highly evident and cannot be ignored.

The popularity of one-stop-shopping continues to build
Slovenian consumers generally enjoy purchasing many grocery items at one place, which is the main reason for grocery retailers holding the vast majority of distribution share within packaged food in the country throughout the review period. Supermarkets/hypermarkets remains the most popular distribution channel for packaged food in Slovenia, although the popularity of discounters increased during the second half of the review period as the global economic crisis took its toll on Slovenia’s economy. This was mainly due to the lower prices attached to the products offered within discounters outlets, which attract a significant proportion of Slovenia’s generally price-sensitive consumers. Apart from large format grocery retailers, other important distribution channels for packaged food in Slovenia are small grocery retailers, specifically convenience stores, which was the most important small grocery retailers channel for the distribution of packaged food in Slovenia during 2011. However, these small grocery retailers channels are steadily losing distribution value share in the majority of packaged food categories due to still rising popularity of one-stop shopping and the rising demand for the lower prices charged for goods through chained large format grocery retailers.

The future of packaged food in Slovenia remains positive
Packaged food in Slovenia is expected to perform well during 2011, with positive value sales growth also expected to continue throughout the forecast period. However, when comparing the projected performance of packaged food in Slovenia for the forecast period with the growth registered during the review period, it is clear that the growth rates are set to be lower during the forecast period than they were during the review period. This is expected to be mainly due to the lingering effects of the financial and economic instability in Europe, specifically in smaller countries of the Eurozone, and the ongoing price-sensitivity of Slovenian consumers. As soon as the global and regional economic situation improves, however, value sales growth rates in packaged food in Slovenia can be expected to begin rising again.

Thursday, 8 December 2011

Orphan Drug Trends 2011

Orphan Drug Trends 2011 - With the industry’s ongoing transition toward more niche high-value therapies, a growing number of companies are expanding into the orphan drugs arena, fuelled by the incentives offered by national regulatory authorities, the high price point orphan drugs can achieve, and the limited competition they face.

Features and benefits

An overview of orphan drug designation policies in the major pharmaceutical markets
Insight into pricing and reimbursement challenges faced by orphan drug manufacturers
Review of Orphan Drug Market R&D, designation, and approval trends in the US market
Orphan drug deal trend and case study analysis

• With the growing number of orphan drugs entering the market, products are facing tougher scrutiny from payers, with pricing and reimbursement remaining the most significant hurdle to market access, leading to the use of risk-sharing agreements by a number of manufacturers.
• Pharma’s shift toward niche markets is occurring either by gradually undertaking several bolt-on deals with specialist players, as exemplified by GlaxoSmithKline and Pfizer, or opting for a large scale merger or acquisition to rapidly access the target company’s orphan drug portfolio, as illustrated by Sanofi’s purchase of Genzyme.
• The majority of orphan drug candidates targeted by pharma are in Phase III clinical trials, and are accessed primarily through licensing deals. Nevertheless, pharma is also keen to access orphan drugs during pre-clinical development. Often these deals involve smaller up-front fees, with greater emphasis on commercial milestone and royalty payments.

UK SME Insurance 2011

UK SME Insurance 2011 - The small and medium-sized enterprise (SME) market is very competitive and is currently evolving as the commoditized personal lines market starts to influence and shape it with the development of electronic trading and online distribution channels. This report explores the issues affecting the market and highlights the leading insurers.

Browse All: Financial Services Market Research Reports

Features and benefits
Detailed SME research into buying behaviour, insurance needs, and industry differences.
Data on the top insurers per line of business and distribution channel was used.
Analysis of how e-trading is evolving in this market.
Estimated market size and five year forecast.

Table Of Contents

Total SME market is estimated at GWP of £5.2bn
Companies that employ 1–49 employees form the largest part of the SME segment
The number of enterprises grew in 2009 and 2010 after a flat 2008
In 2010, the number of enterprises grew by 2.6% to 4.4 million
More than 99.8% of UK companies are small or medium-sized businesses
What insurance do SMEs buy?
SMEs buy a range of covers
Most SMEs choose to purchase through a broker
57.5% of SMEs approached a broker for their insurance
Price comparison sites are targeting SMEs
The four main comparison sites all offer business insurance
Switching behavior is increasing
More SMEs are switching providers
Small commercial business insurance is now available online
The SME insurance market is showing signs of following the personal lines market
Over half of the brokers surveyed use a marketplace portal
Brokers also use insurers' extranets
Nearly 60% of those brokers that purchase through extranet sites use Aviva's site
Online portals will take off once there are more products on them
45.2% of brokers only need 6 products available
Brokers name Aviva as the leading insurer for small packaged business
17.8% of brokers surveyed place the largest single proportion of their business with Aviva
Total SME market will grow to £6.4bn in GWP by 2015
SME market to grow in line with total commercial market

Total SME market is estimated at GWP of £5.2bn
Companies that employ 1–49 employees form the largest part of the SME segment
The number of enterprises grew in 2009 and 2010 after a flat 2008
In 2010, the number of enterprises grew by 2.6% to 4.4 million
More than 99.8% of UK companies are small or medium-sized businesses
The number of new companies has grown in the past two years
The number of company liquidations has slowed
SME market by industry
Construction forms the largest part of the SME market
What insurance do SMEs buy?

UK Travel Insurance 2011

The report UK Travel Insurance 2011 includes a discussion of the performance of the major travel insurance competitors, providing data on GWP and market share. It puts this data into context with a discussion of key market issues, and also features a discussion of advertising trends that point towards competitor strategies and market trends.

Features and benefits
• The latest data and market research including information on market size, drivers behind claims and travel trends.
• Insight into advertising expenditure and consumer behaviour in the market.
• An understanding of the competitive environment, new partnerships, and the impact key players are having on the travel insurance market.
• Forecasts of the market’s GWP growth until 2015, based on industry interviews, secondary research and in-house expertise.

Browse All: Banking Market Research Reports

The total number of visits abroad by UK residents fell by 6.3% in 2010. This represents a drop from 58.6m to 54.9m. Foreign travel has seen a downturn since 2008, with an average rate of decline at 5.3% between 2006 and 2010.

AXA continued to hold the largest share of the travel insurance market in 2010, with 20.2%, representing a GWP of £154.3m. This was however both a decrease in GWP – down by 2.0% - and market share, with a 1.0% decline. Performance is expected to improve with a continued partnership with Lloyds TSB and the new account with TUI.

Single trip polices were the most popular choice of travel insurance coverage for all age bands except for the oldest group, 55-65 year olds. 18-24 year olds were the most likely to purchase single trip polices, with 54.7% of respondents selecting this option.

Tuesday, 6 December 2011

Packaged Food in Bosnia-Herzegovina

Published: November 2011
Price: $ 6500

Growth, inflation, recession, recovery
During the first half of the review period the Bosnia-Herzegovina Packaged Food Market grew strongly. Main drivers of the market in 2006 and 2007 were expansion of consumers’ disposable income and penetration of large chained retailers, which significantly improved the range of products offered to consumers in Bosnia-Herzegovina. 2008 is the year remembered by volatility of food prices across the world. This was the first in a series of shocks which followed until 2011. During 2009 the global financial crisis spread to Bosnia-Herzegovina and the domestic economy grinded to a halt and began to decline. Recession continued throughout 2010. This negativity in the environment was reflected in a significant decline of Bosnian and Herzegovinian consumers’ disposable income. Like most fast-moving consumer goods, sales of packaged food suffered. However, some categories performed better than others, for example private label brands and basic foodstuffs. In 2011 we begin to see first signs of market recovery in Bosnia-Herzegovina.

Inflation and high unemployment delay serious recovery
The packaged food market as well as the economy in Bosnia-Herzegovina began to recover from the recession during 2011. Still, it is not all blue skies yet. Prices of basic foodstuffs started to grow at the end of 2010 and continued going up in 2011. Categories most affected by price volatility are chocolate confectionery, bakery products and oils and fats, incidentally the same categories which drove price inflation during 2008. Nevertheless, 2011 performance of packaged foods in Bosnia-Herzegovina is expected to be an improvement relative to 2010 and 2009. Manufacturers and retailers have adapted their portfolios, focusing on economy products and private label. Purchasing power of consumers is still negatively affected by a high unemployment rate, but there is work to be found in grey areas of the economy.

Dominance of large regional players
Packaged Food in Bosnia-Herzegovina - Several large regional manufacturing groups have established their dominance over the packaged food market in Bosnia-Herzegovina. Packaged food manufacturing companies run by the Croatian concern Agrokor are heading the market, relying on strong support from its sister company Konzum, which grew into an absolute leader in Bosnian and Herzegovinian grocery retailing during the review period. Danube Foods and Podravka have also managed to leverage their wide production portfolios and financial superiority to claim the remaining spots on top of the packaged foods market in Bosnia-Herzegovina. Bosnian and Herzegovinian consumers are obviously assigning great value to regional brands, perceiving them to offer best value for money. Domestic manufacturers are often perceived to offer inferior quality, which is why they need to price their products below those of regional and international competition.

Polarisation of retailing
Packaged food retailing in Bosnia-Herzegovina continues to be dominated by small grocery retailers, but these outlets are losing ground to large retailers, as supermarkets/ hypermarkets has continued to gain value share over the review period at the expense of independent small grocers. These outlets are able to offer best deals to consumers that are increasingly interested in price. Hence, strong performance of private label. Retailers which have achieved largest penetration of private label in their outlets are: Konzum, Mercator, Tus and DM. Large retail outlets are also able to offer consumers the widest range of brands and products to choose from. Independent small retailers are forced to specialise, increasingly serving as convenience specialists, price specialists or food specialists. Since leading manufacturers shifted their focus towards key accounts (large chained retailers), smaller manufacturers with limited advertising resources are beginning to focus on smaller independents where they can achieve better visibility and better sales. Convenience stores, in keeping with the general trend towards convenience, has increased its share over the review period.

Monday, 28 November 2011

The Market Outlook for Refurbished Medical Devices to 2016

Published: November 2011
No. of Pages: 88
Price: $ 3835
This report gives a thorough analysis of the refurbished medical devices market segment. The regulatory environment for refurbished devices is assessed in 92 countries. Opportunities within this market are assessed by device type and by country. A thorough analysis of who the end users for refurbished devices are and what their demands are, with strategies and best practices for growth discussed.

• Analyze the forecast size of the refurbished medical devices market through to 2016.
• Understand the drivers and resistors of the uptake of refurbished medical devices in public and private settings.
• Compare and understand the regulatory environments for refurbished medical devices in 92 countries and discover the key opportunities in them.
• Analyze the various market segments that make up the refurbished devices market and understand what is affecting them.
• Assess who the key end-users are for refurbished medical devices and how they make decisions on which devices to purchase.

• Small hospitals with bed sizes of up to 200 represent the largest end-user segment for refurbished medical devices. This is followed by private practitioners and clinics that purchase over 30% of the total refurbished medical devices sold globally.
• The US is the largest market for refurbished medical devices. One of the dominant market drivers for refurbished medical devices in the US is the presence of a large private healthcare sector consisting of large private hospitals, clinics, and diagnostic centers. In contrast growth opportunities in western European markets are limited.
• Several vendors of high-end refurbished medical devices are now looking to offer 0% leasing finance for hospitals. It is an attractive option for end users as they only need to sign a few documents and make a small down payment before the equipment is installed at 0% interest rates.

• How big are the opportunities within the refurbished medical devices market, and which countries present the best opportunities?
• Which countries allow the import and sale of refurbished medical devices?
• How do the EU and US regulate refurbished medical devices and what are their requirements?
• Which segments of this market have the greatest sales potential?
• Who are the key end-users of refurbished medical devices and what are their needs and requirements?

The Future of Heart Health Food and Drinks

Published: November 2011
No. of Pages: 90
Price: $ 2875

Cardiovascular disorders such as elevated blood cholesterol levels, hypertension, and impaired blood circulation represent a major public health issue and are the number one cause of mortality globally. The WHO estimates that 29% of all global deaths in 2004 were due to cardiovascular diseases. This report examines the emerging market for food and drink products that target heart health.

• Examine market data illustrating the size of the heart health products market.
• Utilize product launch analysis to assess the potential of individual product categories for future innovation.
• Use clinical trials analysis to identify the ingredients being used to target heart health.
• Use a patents landscape to examine the manufacturers who are innovating with heart health ingredients.
• Understand why the functional food market is encouraging the convergence of the food and pharma industries.

• The US makes up the largest single heart health food and drinks market, capturing around two thirds of the overall sector ($6.8bn in 2009), and is forecast to reach $10.5bn by 2015. In terms of product category, bakery and cereals dominates the heart health food and drinks market.
• Hot and soft drinks made up almost a third of the heart health market during 2008–10 in terms of NPD. Fruit juices, tea, and dairy drinks were the most significant sub-categories in terms of product launches with heart health claims. Manufacturers are utilizing many different ingredients including omega-3, phytosterols, and various vitamins.
• The first health claims authorized by the European Commission pertained to cardiovascular health benefits. Plant phytosterols have been approved to lower blood cholesterol levels, water-soluble tomato concentrate for helping healthy blood flow, and more recently oat beta-glucan has been authorized to carry a cholesterol reduction health claim.

• How much is the heart health food and drinks market worth?
• How does heart health compare to other therapeutic areas in terms of new product development?
• Which categories are most commonly used for heart health-orientated products?
• Which companies are leading the way in terms of innovation in heart health ingredient development?
• How will regulatory changes affect this market?

Thursday, 24 November 2011

Strategies for Increasing Share in MVAS Market in BRIC Countries

Published: November 2011
No. of Pages: 86
Price: $ 2950

The report Strategies for Increasing Share in MVAS Market in BRIC Countries provides top-level market analysis, information and insights, including:
• In-depth analysis of the mobile value-added services (MVAS) market in the four BRIC countries: Brazil, Russia, India and China
• A comprehensive understanding of country-specific market trends, drivers, opportunities and challenges across key MVAS service segments
• Detailed market sizes for each BRIC country for a period of 10 years (2007–2016), broken down into four key areas of service

Executive Summary
While the MVAS markets in each of the four BRIC countries have their own distinct drivers, characteristics and challenges, they all offer immense potential to operators with the relevant market knowledge and presence. The growth of the smartphone, social networking and issues relating to 3G and 4G technology are common to all four countries, while the growing level of urbanization is also a key consideration. There is, however, no “one-size-fits-all” approach to capitalize on these opportunities; each country requires its own specific strategy to enable mobile operators to gain market share effectively, taking into account the future drivers and challenges which could potentially affect the growth of these remarkable emerging markets.

This report provides an extensive analysis of the mobile content services market of the four BRIC nations: Brazil, Russia, India and China:
• It provides historical and forecast market sizes for the mobile communication, entertainment, information, and e-commerce services in each of the BRIC nations
• It offers detailed analysis of the factors driving the growth of mobile content services, and the key emerging trends in each of the BRIC nations
• The report details the key challenges, both technical and market-related, faced by mobile operators providing mobile data services
• It provides case examples of key telecommunications operators offering mobile content services

Reasons To Buy
• Gain in-depth insight into the individual mobile content services markets in each of the BRIC countries
• Understand the various market dynamics within the BRIC countries’ mobile and telecommunications industries, and use the knowledge to capitalize on the potential of these high-growth markets
• Take informed decisions and formulate effective technical and marketing strategies based on the report’s detailed market insights on the mobile content services market
• Identify the key specific growth segments within the mobile content services market in each of the BRIC countries
• Understand the growth strategies adopted by key mobile content service providers

Key Highlights
• The BRIC countries are high-growth telecommunication market with extraordinary potential. Each country is undergoing a rapid transition across the mobile value chain, from the launch of cutting-edge services and low-cost infrastructure, to new business strategies and the adoption of advanced technology platforms
• Entertainment and mobile commerce services will be the primary drivers for MVAS growth in BRIC, with the increased penetration of smartphones providing the main impetus
• Revenues from Brazil’s MVAS segment will record a CAGR of 20% over the report’s forecast period, driven by the growth of mobile TV, video and gaming services
• The Russian mobile data market is registering strong growth rates, especially in the mobile TV, gaming and payments sectors
• The Indian telecommunications industry has one of the highest growth rates of all the emerging markets. Its market potential could, however, be affected by limited data-service adoption as a result of a large prepaid subscriber base, low wireless internet penetration and a lack of 3G-enabled smartphones
• China already has more than 900 million mobile subscribers, and operators are investing in 3G and 4G technology, including low-cost 3G-enabled smartphones.

Sunday, 20 November 2011

Life Insurance in India, Key Trends and Opportunities to 2015

Published: November 2011
No. of Pages: 242
Price: $ 1950

The report provides top-level market analysis, information and insights of the Indian life insurance industry, including:
• The Indian life insurance industry’s growth prospects by product category and customer segment
• The various distribution channels in the Indian life insurance industry
• The competitive landscape in the life insurance industry
• A description of the life reinsurance market in India

Executive Summary
India’s insurance sector is expected to grow even faster than the country’s overall economic growth, opening up new business avenues across the industry. With a large number of insurance providers already operating in the country, the Indian insurance industry has shown early signs of entering a consolidation phase, and an improved distribution infrastructure, the adoption of new channels and differentiated product offerings will continue to change the competitive landscape significantly.
India’s low life insurance penetration rate and the rising awareness of the need for insurance will be key growth factors in the Indian insurance industry. Favorable foreign investment policies and increased capital-raising options will also create an environment for collaborations and joint ventures. India’s reinsurance market is also expected to continue growing, driven mainly by growth in non-life and accident and health insurance."

This report provides a comprehensive analysis of the life insurance market in India:
• It provides historical values for India’s life insurance industry for the report’s 2006–2010 review period and forecast figures for the 2011–2015 forecast period
• It offers a detailed analysis of the key sub-segments in India’s life insurance industry, along with market forecasts until 2015
• It covers an exhaustive list of parameters, including written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, frauds and crimes, total assets, total investment income and retentions
• It analyses the various distribution channels for life insurance products in India
• Using Porter’s industry-standard “Five Forces” analysis, it details the competitive landscape in India for the life insurance business
• It provides a detailed analysis of the reinsurance market in India and its growth prospects
• It profiles the top life insurance companies in India, and outlines the key regulations affecting them

Reasons To Buy
• Make strategic business decisions using top-level historic and forecast market data related to the Indian life insurance industry and each sector within it
• Understand the demand-side dynamics, key market trends and growth opportunities within the Indian life insurance industry
• Assess the competitive dynamics in the life insurance industry, along with the reinsurance segment
• Identify the growth opportunities and industry dynamics within seven key product categories
• Gain insights into key regulations governing the Indian insurance industry and its impact on companies and the industry's future

Key Highlights
• The significant growth in the Indian life insurance market in the review period can be attributed to key growth drivers such as population growth, robust economic growth, lucrative tax benefits, the rising disposable income of India’s middle-class population, and increased awareness of the need for insurance, especially among younger people
• India is the world’s twelfth-largest life insurance market, and the fourth-largest in the Asia-Pacific region
• By 2015, it is expected to surpass South Korea to emerge as the third-largest life insurance Asia-Pacific market after China and Japan
• In 2010, the individual life insurance segment accounted for 74.8% of the total Indian life insurance industry, whereas the group life insurance market had a considerably lower market share of 25.2%
• Indian customers are increasingly demanding insurance products that offer assured income through annuities
• Distribution channels such as bancassurance have gained significant market share in the review period

Friday, 18 November 2011

European Markets for Ophthalmic Devices 2011 (Diagnostic & Invasive)

Published: November 2011
Price: $ 11495
In 2010, the European diagnostic and interventional ophthalmic device market was valued at over €650 million. The rate of market growth will accelerate due to increases in ocular conditions such as cataracts. The European ophthalmic devices market includes diagnostic devices that are used for identifying ocular conditions, such as cataracts, glaucoma retinal detachments, and refractive problems. The interventional device market included intraocular lenses (IOLs), which are implantable lenses used for replacing the natural lens when it has been damaged by cataracts.

The market segments covered in this report include: 
• Optical Coherence Tomographers
• Fundus Cameras
• Slit Lamps
• Perimeters
• Tonometers
• Ophthalmic Ultrasound Equipment
• Wavefront Aberrometers
• Corneal Topographers
• Intraocular Lenses
• Phacoemulsification Consoles
• Ophthalmic Viscosurgical Devices

The countries covered in this report include:
• Austria
• Benelux
• France
• Germany
• Italy
• Portugal
• Scandinavia
• Spain
• Switzerland
• The United Kingdom

Within the European Ophthalmic device market, companies such as Alcon, AMO, Bausch & Lomb, Carl Zeiss, Haag-Streit, Meditec and Oculus lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

China Permanent Magnet Switch Industry Report, 2011

Published: November 2011
No. of Pages: 58
Price: $ 1500

Permanent magnet switches refer to electric switches with permanent magnetic actuators. Compared with conventional spring actuator switches, they hold a lot of advantages, say, less components, smaller size, longer life and higher performance, and serve as substitutes for spring switches.

China permanent magnet switch industry is still at the primary stage of development. In 2010, China produced only 35,000 sets of permanent magnet switches. As their performance has been improved gradually and promotion has been enhanced, permanent magnet switches will be applied more widely in large-scale industrial enterprises in steel, petrochemical, coal, etc. It is estimated that the market scale of permanent magnet switches will increase to 65,000 sets in China in 2015 with the average growth rate of 13.18%.

Browse All: Industry Profiles Market

At present, large permanent magnet switch manufacturers can be mainly divided into foreign-funded and China-funded enterprises in China.

Tavrida Electric and ABB are representatives in the first category. Tavrida’s products mainly serve China railway system, while ABB focuses on smart grid. Besides, Schneider Electric and Eton have also launched small batches of products into the Chinese market.

Yongda Group is a prominent China-funded enterprise, occupying 21.92% of the Chinese permanent magnet switch market in 2010. Till Oct. 2011, Yongda Group has achieved mass production of 12kV and 40.5kV permanent magnet switches, and successfully developed 24kV and 31.5kV permanent magnet switches but still without mass production. Chinese enterprises which can massively produce permanent magnet switches also include CREAT, Dongyuan Electrical, Xinlong Electrical, Senyuan Electric, etc.

China Permanent Magnet Switch Industry Forecast Report, 2011” of ResearchInChina mainly covers the following contents:
• Policies for and features of China permanent magnet switch industry;
• 2012-2015 forecast of China permanent magnet switch industry, including the forecast of output, output value and profit;
• Development of foreign-funded permanent magnet switch enterprises in China, including the overall development, expansion in China, and market promotion of permanent magnet switch products in China;
• Development of China-funded permanent magnet switch enterprises, including the overall operation, permanent magnet switch product R&D, production, capacity, output, development plan, etc.

Monday, 7 November 2011

Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems

Published: November 2011
No. of Pages: 150
Price: $ 3500

Radiography includes mammography, computed tomography, traditional x-ray and digital x-ray. These imaging procedures are affected by a number of factors: advances in technology, consumer expectations for healthcare, declining reimbursement and coverage of medical expenses by insurances companies and the aging of the population are among the factors driving these imaging markets.

This report, Medical Imaging Market from Kalorama Information, details these these factors and provides 2011 market size and forecast to 2015 for the following markets
• Digital X-Ray
• Traditional X-Ray
• Dental X-Ray
• Film
• CT
• Mammography
• Fluoroscopy
• Regional Markets (US, Europe, Asia, ROW) for these segments
Digital systems replace the conventional film cassette with an electronic receptor that directly converts the x-rays to digital images. Over the years, Kalorama Information analyst Joe Constance has tracked this trend of digital radiography. Digital technology enables x-ray modalities to detect problem sites more rapidly and with greater accuracy. These capabilities are helping fuel hospitals' transition from film-based systems to filmless environments. At the same time there are practical limiters to digital and areas where film-based systems will still be useful, and the report details these.

This report analyzes the current and potential world market for medical and dental x-ray systems. Various modalities that use x-rays to create images, such as fluoroscopy and CT, are included in the report. Also reviewed is the market for medical and dental x-ray film. This report emphasizes the current and future markets for these products. This report generally reviews the nature and direction of research, as well as future markets. It also profiles several companies involved in marketing medical and dental x-ray equipment, and medical and dental x-ray film, including:
• Adimec
• AFP Imaging Corp.
• Canon Inc.
• Carestream Health Inc.
• C.M.C. Biotech Co. Ltd.
• dpiX LLC
• Fischer Industries Inc.
• Tower Semiconductor Ltd.
• Trixell
• United Radiology Systems Inc.
• Varian Medical Systems
Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. The market data provide multiple year forecasts for all product segments covered in the report. The information presented in this report has been generated by data gathered from company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press. In addition, interviews were conducted with company executives.

Browse All: Medical Devices Market

Dramatic Change in X-Ray Market as Digital Systems Exceed Traditional
Kalorama Information estimates that digital x-ray system sales will exceed those of traditional x-ray systems used for a medical (non-dental) purpose in 2011. According to the healthcare market research publisher, revenues for digital x-ray systems are the largest component of the $12 billion radiography market, slightly higher than the firm's projection for traditional systems. Kalorama notes in its new report: Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems, that digital x-ray will exhibit the highest growth in the radiography market which includes mammography, fluoroscopy, dental imaging, computed tomography, and analog x-ray systems.

The report states that it is initially expensive to purchase a digital x-ray system such as the Philips DigitalDiagnost, the Siemens AXIOM Multix, or products from several other companies. But with continued use, operating costs are lower than with standard radiography. Digital systems don't require film and processing, the annual cost of which can be as great as the capital cost of standard radiographic equipment. And, once a digital system is installed, large film storage facilities are no longer needed.

"The initial cost of buying a digital system is several times higher than a conventional system," said Joe Constance, the report's author and imaging analyst for Kalorama Information. "But the high cost can be justified, particularly in a high volume setting."

Kalorama finds that it is not the cost savings but convenience and usability that are especially driving system sales. Diagnosticians can retrieve digital x-rays almost instantly from a computer terminal. The movement to digitize diagnostic imaging is closely tied to the movement to boost health care efficiency through the digitization of health care records - electronic medical records (EMRs). As a result of steadily increasing digital business, radiology equipment manufacturers that once had significant involvement in film and film-related technologies have been investing in alternative digital technologies.

The report also notes changes in the competitors operating in x-ray equipment. Because innovation relies greatly on funding, large companies with flexible budgets for research and development have owned a sizable percentage of the market. But others, such as Kodak, have left the business. That company decided to focus its attention on the significant digital growth opportunities in consumer and professional imaging and graphic communications.

The report contains analysis of the market including company profiles, regional market breakouts, key trends and market shares of competitors.

Sunday, 16 October 2011

China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets

Published: October2011
No. of Pages: 167
Price: $ 3500

China’s rapid economic development and numerous steps of reform undertaken by the Chinese central government since 1997 had clear and observable effects upon China’s total healthcare services market and product markets for pharmaceuticals, medical devices, and in vitro diagnostics (IVD). This progress has been augmented by a Reform program in 2009, including increased funding, to improve services.

What are the workings of China's healthcare system? How much progress has been made towards the promised vision of the CPCC in 2008 to provide "convenient and affordable access" to its people? What are the effects on foreign companies seeking to benefit from an increase in healthcare-related funding? Where are the best opportunities in China for marketers. Analyst Emil Salazar focuses on these questions.

The report China Healthcare Reform Impact contains a comprehensive overview of the Chinese healthcare system with important data for marketers to China. It discusses healthcare reform plans and where funds were spent. It also describes the role foreign companies play. As part of its analysis, the report includes the following information:
• Statistics on Chinese Hospitals, Community Health Centers and Clinics
• Top and Bottom City Markets for Urban Healthcare
• Top and Bottom Rural Regions
• Challenges for Foreign-Owned MNCs in China
• Government Healthcare Spending
• Foreign-Invested Manufacturing Enterprises in China
• Share of Government Funded Healthcare vs. Out of Pocket
• Domestic Healthcare Industries
• Population and Age Statistics
• Incidence Rates for Infectious Diseases
• Cancer Rates in China
• Regulation of Drugs and Devices in China
• U.S. Product Exports to China
• Key Analyst Conclusions

In addition to providing useful background information and a thorough analysis of China's healthcare changes, the report China Healthcare Reform and Its Impact on IVD, Medical Device and Pharmaceutical Markets provides data for business planning. The report also takes a look at the status and forecast of the three key healthcare markets in China:
• The Chinese Market for IVD products
• Regional Breakout of Chinese IVD Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• The Chinese Market for Medical Device Products
• Regional Breakout of Chinese Medical Device Market (Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Segment Breakout of Chinese Medical Device Market(Surgical Instrument, Disposable, Patient Monitoring, IVD, Imaging, Orthopedic, Other)
• The Chinese Market for Pharmaceutical Products
• Regional Breakout of Pharmaceutical Market(Eastern, Northern, Central, Southern, Southwestern, Northwestern, Northeastern)
• Segment Breakout of Pharmaceutical Market (Cardiovascular, Gastrointestinal, Anti-Infectives, Neurotherapeutics, Oncology, Respiratory, Other)
This essential resource for anyone marketing a healthcare product to China was constructed using a combination of primary and secondary sources. Corporate reports, trade publications government information and medical journals, previous market research studies conducted by Kalorama and other sources were used. In some cases, interviews were used to determine forecasts and key trends.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.

Monday, 10 October 2011

U.S. Market for Dental Prosthetics and CAD/CAM Devices 2011

Published: October 2011
No. of Pages: 275
Price: $ 7495

In 2010, the U.S. market for dental prosthetics, which includes crowns, bridges, inlays/onlays, veneers and dentures, exceeded $11 billion. The market has recovered from the slowdown caused by the economic recession of 2008 and 2009. Lingering effects of the recession continued to affect various segments of the market adversely; however, the prosthetics market is expected to continue to grow as the number of patients requiring dental prosthetics increases.

Browse All: Medical Devices Market Research 

The market segments covered in this report U.S. Market for Dental Prosthetics and CAD/CAM Devices 2011 include:
• Crowns and Bridges
• Inlays and onlays
• Veneers
• Dentures
• CAD/CAM Systems
• CAD/CAM Blocks and Prosthetic Devices
• Intra-Oral Digital Impression-Taking Systems
• Automated Prosthetics Manufacturing
• Rapid Prototyping Systems/3D Printing

Within the dental prosthetics market, companies such as Dental Services Group, Glidewell Laboratories and National Dentex Corporation lead the market. Within the CAD/CAM System market companies such as 3M, DENSPLY and Sirona lead the market. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Monday, 3 October 2011

Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition

Published: October 2011
No. of Pages: 155
Price: $ 3500

Several cell culture-derived biopharmaceutical drugs were launched in the US and European markets in 2010. Biopharmaceuticals (recombinant proteins, monoclonal antibody and nucleic acid-based products) represent the fastest growing sector in the pharmaceutical industry. Driving the extraordinary interest in biopharmaceuticals is the ability of these large proteins to target diseases in a very specific manner, thus maximizing efficacy while minimizing side effects.

Growth in the development and production of biopharmaceuticals is the most significant driver of the cell culture market. Biological products are developed from large and complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. Protein-based biopharmaceuticals are invariably produced by an initial cell culture step (upstream processing), followed by product recovery, purification and formulation into final product format (downstream processing).

This report analyzes the world market for the cell cultures used in these steps and the major trends driving this market. Forecasts and current market sizing are provided in three specific segments:
• Media,
• Sera, and
• Reagents

In addition to a thorough discussion of the technologies and techniques currently employed and emerging in the cell culture area, the Kalorama's exhaustive report provides specific information on:
• Market Size, growth, and forecasts of the segments through 2015
• Competitive Market Share by leading supplier as of 2010.
• Estimated Market Share by Region (North America, Europe, U.S.)
• Key Market Drivers and Restraints for suppliers, including discussions of biopharmaceutical pipelines, biomedical R&D directions, and the future of transgenic plant and animal production.
• Review of the various expression systems (Bacteria, Yeast, Insect, and Mammal) and the biopharmaceutical product manufactured by these systems
• Discussion of the preferences in media types vying for dominance in the market, including the following:
ADCF - animal derived component free media
CD - chemically defined media
CSFM - complete serum free medium
PF - protein free media
SF - serum free media
SFM - serum free medium
• Major Trends Impacting the Market stem cell research (including plans of major companies)cell culture-based vaccine Production and generic bipharmaceuticals
• Profiles of Leading Suppliers and information about M&A activities in recent years

The information for this report Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company and cell culture supply company representatives included marketing directors, division managers, and product representatives.

All Kalorama reports advertise the single user price, which limits access to one user. We also feature department and global pricing for reports that will be utilized by more than one user at your company. Please ask your sales representative or select the correct license on our website.

Wednesday, 21 September 2011

Wireless Opportunities in Healthcare 2011 (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies)

Published: October 2011
No. of Pages: 210
Price: $ 3995

In previous editions of Kalroama Information's wireless technologies market report, we described wireless IT systems and devices being used in some model healthcare environments. The use of these technologies has moved well beyond these settings and should be of interest to marketers of many products, even those outside of healthcare IT. While not every healthcare system has gone wireless, 2011 has seen no letdown in the implementation of these technologies in healthcare. Almost all healthcare organizations have had to adjust to the use of these technologies in some form.

Kalorama’s Wireless in Healthcare 2011 is your guide to the growing market for wireless healthcare applications in the United States. This report contains explanations that cut through the confusion surrounding technologies and provide readers with a total picture of wireless in healthcare.

Current and Future US Markets for Bluetooth, Zigbee, RFID, UWB, WMAN and WLAN
Since the previous edition, some technologies have performed better than others and 2010 results have led to reforecasting of some technologies. The competitive arena has not dramatically changed since last year, with a few key players dominating and opportunity for smaller companies, but developments have been interesting.

Browse All: Healthcare Market

The report provides:
• Discussion of Trends in the Wireless Technology in Healthcare Marketplace, Products and Customer Case Studies of Wireless Applications.
• Current Revenues and Forecasts to 2015 for all Wireless Technologies by Healthcare Application.
• Current Revenues and Forecasts to 2015 for all Wireless Technologies by Technology Type.
• Scores of Tables and Figures provide accessible information about the wireless in healthcare marketplace.
• Detailed Profiles of 9 Key Companies in this market, major products and key executives.
• Explanation of the Major Technologies, ( Zigbee, Bluetooth, RFID, UWB, WMAN and WLAN )that are being used in healthcare.

Because of the focus on healthcare IT in the United States, the report focuses on this region. Some discussion of non-US opportunities and company efforts is included. The report provides today’s market figures and realistic projections for future revenues based on consideration of data and extensive interviews with industry experts. Looking at several detailed case studies, the report shows how wireless is already being used by major healthcare companies across a wide variety of applications, including:
• Hospitals
• Homecare and Telemedicine
• Pharmaceutical Research (Clinical Drug Trials)
• Inventory Control
• Pharmaceutical Sales Force Management
• Inventory Control
• Physician Offices
• Nursing Homes
• Medical and Diagnostic Laboratories
• Patient Monitoring

Case Studies
The report looks at several case studies where wireless technologies were implemented at various healthcare concerns and assesses the benefits derived from implementaton. Some case studies include:
• Sentara Healthcare's Electronic Medical Records and Wireless Technologies Information Technology System
• Rural Wireless Healthcare: 3G Mobile Medicine Partners in 3G Mobile Medicine Project
• George Washington University Hospital - WLAN Implementation
• Meridian At Home Pilot Program, Benefits of Implementation
• Memorial Medical Center - WLAN Implementation Requirement for Implementation of Wireless Technologies
• Cardinal Health and RFID Implementation
• Achieve Healthcare Technologies - e-Prescription
• Bayer Healthcare - e-Drug Trials and Requirement for e-Drug Trials

The report details the companies in this field - and why there is still an opportunity for new competitors. It discusses the currently implemented technologies and the technologies to watch that in four years, will gain impressive market share. Finally, it describes the trends that will push market expansion and reduction of cost of these devices. The healthcare applications and marketplace for the following technologies are discussed in detail:
• Bluetooth,
• Zigbee,
• Wireless Local Area Networks (WLAN)
• Wireless Metropolitan Area Networks (WMAN)
• Wireless Wide Area Networks (WWAN)

As a global report, Wireless Opportunities in Healthcare will look at opportunities available in the European Union and at Asian markets, while focusing on the US market
Kalorama’s unique and thorough research process provides an exhaustive analysis of this evolving market. Information was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. For the purpose of this study, Kalorama Information conducted telephone and email interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with wireless technology company representatives included marketing directors, division managers, and product development representatives.

In addition to superior coverage of the overall wireless healthcare market, in-depth company profiles are included for the following wireless technology companies:
• Allscripts Healthcare Solutions, inc.
• Cerner Corporation
• Cisco Systems, Inc.
• Extreme Networks, Inc.
• GE Healthcare
• Hewlett Packard Corporation
• McKesson Corporation
• Medtronic, Inc.
• Motorola Solutions, Inc.
• Philips Healthcare
• Siemens Healthcare

Tuesday, 20 September 2011

Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations) Pre-Publication

Published: October 2011
No. of Pages: 150
Price: $ 2995

Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. The decentralized testing market is experiencing growth faster than the diagnostic markets at large and over the long term will create opportunities for innovative companies.

Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with fastest growth, and infectious disease has surfaced as one of those segments. This report, Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations), examines this segment, and especially new threats for which there are large markets in the developing world and in developed countries.

Browse All: Pharmaceuticals Market Research

An Opportunity For Test Makers
Infectious disease is a broad category, and in some disease areas, diagnostic companies already own market share. Increasingly hospitals and clinics are seeing new infectious disease threats and tests are being developed to assist them. Within the infectious disease testing market, this report details the opportunities that could be found when diseases of the developing world enter the healthcare system of the developed. This report provides market projections for point of care diagnostics in the developed and developing world for the following infectious diseases:
    * Chagas Disease, Rapid Test Market Forecast to 2016
    * Chikungunya, Rapid Test Market Forecast to 2016
    * Dengue Fever, Rapid Test Market Forecast to 2016
    * HIV, Rapid Test Market Current Size and Forecast to 2016
    * HPV, Rapid Test Market Current Size and Forecast to 2016
    * Leishmaniasis, Rapid Test Market Forecast to 2016
    * Onchocerciasis (River Blindness), Rapid Test Market Forecast to 2016
    * STDs, Rapid Test Market Current Size and Forecast to 2016
    * Tuberculosis, Rapid Test Market Forecast to 2016

In addition the report also provides:
    * The Overall Point of Care Diagnostics Market
    * Economics of Financial and International Programs
    * Company Profiles of Leaders in the POC Infectious Disease Market
    * EMR and Connectivity Issues
    * Tests in Development
    * The Role of Drug Resistance
    * Disease Statistics

Technical and Market Considerations
Many reports provide market projections, but those projections rely on the development of new tests which will enter the market. This report considers the technical factors behind product development. Tests for diseases can only be provided where the technical means to develop a test exist. This report also deals with the technical choices, possibilities and limitations to today's tests. Reagent issues, testing on strips, instrumented and non-instrumented tests. These factors will impact the tests that reach the market.

The World Market for Cancer Therapeutics and Biotherapeutics, 4th Edition (Pre-Publication)

Published: October2011
No. of Pages: 245
Price: $ 2995

This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics, 4th Edition - focuses on several segments for cancer treatment including:
• Chemotherapy, including -subcategories Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives -Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar with Market Share for each
• Hormone Therapy: -Subcategories include Corticosteroids, Hormone Agonists/Antagonists, Aromatase Inhibitors and SERMS-Brands such as Arimidex, Casodex, Zoladex, Femara and Lupron with Market Share for each.
• Immunotherapy and Biotherapy, including: -Monoclonal antibodies, interleukins/interferons, vaccines and other biotherapy-Brands such as Rituxan, Herceptin, Gleevec, Evastin and Erbitux
One of the most promising new approaches in modern cancer treatment is immunotherapy or biotherapy, the development of methods to augment and enhance the body’s natural tendency to defend itself against malignant tumors without damaging healthy tissue. The report devotes particular attention to these new therapies.

This report, Kalorama's fourth complete research effort into the oncology treatments market in the past ten years, provides market size information for the various types of cancers including the following:
• Bladder
• Breast
• Cervical
• Colorectal
• Esophageal
• Head/Neck
• Kidney
• Leukemia
• Liver
• Lung
• Lymphoma
• Melanoma
• Multiple Myeloma
• Neuroblastoma
• Ovarian
• Pancreatic
• Prostate
• Stomach

The report covers both currently marketed and late stage development cancer products. Revenues for each current market segment were generated using dollar and unit sales for each product.
The report includes statistical information for cancers by type worldwide, with special emphasis on the U.S. market. Specifically, cancers where there are current products available or are in development and/or have significant incidence/mortality rates are profiled. The market segments provide an overview, description of products on the market, leading product sales, market estimates and forecasts, and competitive analysis of leading providers. The report also includes a list of products in development and current issues and trends affecting the industry.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

As part of its coverage, the report looks at the following trends
• Insurance and Reimbursement Issues
• Cancer Drug Costs
• Personalized Medicine
• Targeted Cancer Therapy
• Pharmacogenomics
• Alliances Acquisitions and Licensing Agreements
• Patient-Reported Outcomes
• Alcohol’s Affect on Cancer Incidence
• Healthy Lifestyles Continue to Show Promise for Cancer Prevention
• Obesity in the U.S.
• Outlook for a Healthier U.S. Population
• Cancer Trends
• Marketing and Distribution Trends
• Geographical Trends (US, Europe, Japan)
• Elderly Clinical Trial Involvement
• Late-Stage Drug Development Trends

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2010. Historical data was provided for the years 2005 through 2009, with forecast data provided for 2011 through 2015. Compound annual growth rates (CAGRs) are provided for the 2005-2010, 2010-2015 and 2005-2015 periods for each industry segment covered. Competitive analysis is provided for the year 2010. The forecasted market analysis for 2010-2015 was based on probability of approval and sales of products in late stage development, competitive trends, product marketing, and demographic trends.

Tuesday, 13 September 2011

Remote and Wireless Patient Monitoring Markets

Published: August 2011
No. of Pages: 167
Price: $ 3995

Advanced patient monitoring systems that provide wireless or remote patient monitoring to share data outside the immediate patient care area continue to see sales growth. Features on these devices can range from basic remote tracking ability to “face-to-face” interaction between clinicians and patients or even data sorting of the vast amount of data collected in order to put it into the context of a patient’s condition. Many systems now transfer data to an electronic medical record (EMR), and some come with full-service outsourcing.

This Kalorama Information report, Remote and Wireless Patient Monitoring Markets covers three product areas: wireless and remote patient monitors, patient data processing applications and equipment, and EMR data transfer equipment and applications, which coordinate the flow of data to hospital electronic medical record system. Data is provided for the US market in 2010 and forecasted to 2015.

There are four primary markets for these new technologies, which are as follows:
• Hospitals;
• Home healthcare;
• Nursing homes; and
• Other (including first responders, institutional, physician offices, and military)

In addition to providing market sizes by venue serviced, the report also breaks out the market for remote and wireless patient monitoring based on the disease category being monitored by these devices for the following categories:
• Asthma Monitoring
• COPD Monitoring
• CHF Monitoring
• CHD Monitoring
• Cancer Monitoring
• Diabetes Monitoring
• Other Disease Monitoring
Patient data processing applications and equipment use algorithms to evaluate monitoring measurements for a patient’s specific condition(s). Usually, these can be customized by the physician, with reports sent to the physician. In the market for high-tech patient monitoring systems, the applications and equipment are either integrated into the patient monitoring system or are add-ons to the measuring systems. As with data processing, EMR data transfer equipment and applications for this report are either components of, or add-ons to, patient monitoring systems. This report does not include EMR applications.

Most players in the market are discussed as part of Kalorama's competitive analysis of the remote patient monitoring market. As part of our coverage of the marketplace for remote and wireless systems, several major manufacturers are profiled in detail in this report This report was constructed using both a primary and secondary research approach. Annual reports, trade publications and other sources were thoroughly researched, but interviews were conducted among industry executives were used to make assessments of markets and to discover trends and construct forecasts.

Wednesday, 7 September 2011

Convenience Store Foodservice Trends in the U.S.

Published: September 2011
No. of Pages: 100
Price: $ 3995

Packaged Facts’ Convenience Store Foodservice Trends in the U.S. estimates that convenience store foodservice sales grew 5.6% in 2010, and we forecast sales to rise by 5.8% in 2011 and 5.3% in 2012, on the heels of aggressive foodservice platform build outs and increased convenience store foodservice patronage. In the process, foodservice is transforming the convenience store user experience, forcing players to improve their platforms or get left behind.

Convenience Store Foodservice Trends in the U.S. helps industry participants understand and leverage key trends shaping category growth, including:
• Analysis of convenience store users’ intended and actual purchases (by product category), to help participants develop trip consolidation strategies that increase guest traffic and leverage sales of other merchandise.
• Analysis of intended and actual foodservice purchases, to help participants leverage foodservice platforms as part of their trip consolidation strategies.
• Convenience store foodservice sales growth trends, by foodservice category (prepared foods, hot dispensed beverages, cold dispensed beverages, and frozen beverages), to help foodservice suppliers and operators develop menu items on trend.
• Prepared foods retail segment cross-usage analysis, to assess the degree of prepared foods competition among conveniences stores, grocery store/supermarket and fast food/QSR players and help position opportunity.
• Guest traffic analysis for the foodservice industry by segment; convenience stores, and convenience store foodservice, to identify opportunity among key demographic groups.
• Quick Bite” food health attribute analysis, to develop on-the-go meal solutions and snacks in accordance with consumer health preferences.
• Convenience store foodservice purchase considerations, to develop and position menu items and craft marketing messages in accordance with consumer purchase rationales.
• Competitive foodservice analysis of five leading convenience store foodservice programs, to learn how these leading players are developing and adapting their foodservice platforms. Foodservice strategies, foodservice sales growth, menu analysis, and consumer usage demographics are included.

Tuesday, 30 August 2011

Medical Imaging Markets: Image-Guided Surgery

Published: August 2011
No. of Pages:130
Price: $ 3500

Imaging technology used to diagnose illness and injury is increasingly being used to assist surgeons complete procedures. Interventional radiology or image-guided surgery involves the use of a real-time correlation of the operative field to preoperative imaging data that reflect the precise location of a surgical instrument to the surrounding anatomical structures. Preoperative scans from different imaging modalities provide additional diagnostic information. These scans can help a surgeon assess the adequacy of a repair.

As the number of minimally invasive surgical procedures has increased, though, other imaging modalities have been applied to address the limitations of x-rays and fluoroscopy. Computed tomography (CT), magnetic resonance imaging (MRI), ultrasound and molecular imaging have provided the information required to plan and perform complex interventions inside the body without the need for direct open visual inspection by a surgeon.

Kalorama Information's Medical Imaging Markets: Image-Guided Surgery provides insight into the use of imaging to assist surgical performance, with procedure and market data for the US, Europe, Asia and ROW for the following modalities:
• X-Ray Fluoroscopy
• CT
• Ultrasound
The report also provides revenue and procedure numbers based on procedures completed.

The following companies active in this field are profiled:
• B K Medical
• Brainlab AG
• Compass International Innovations
• Curexo Technology Corp.
• Elekta AB
• GE Healthcare
• Image Guided Therapy
• Imris
• Integra Lifesciences Holdings
• Medtronic
• NDS Surgical Imaging
• Philips Healthcare
• Siemens Healthcare
• SiteSelect Inc.
• Smith & Nephew plc
• St. Jude Medical Inc.
• Stryker Corp.
• SurgiVision Inc.
• Toshiba America Medical Systems Inc.
• TrueVision Systems
• Ultrasonix Medical Corp.
• Xograph Healthcare Ltd.
• Varian Medical Systems Inc.
• Vital Images Inc.
• Zimmer

The report also examines trends in the industry, including:
• Partnering for Image-Guided Surgery
• Improved Vascular Guidance
• Image-Guided Biopsies on the Rise
• Radiologists’ Role Increases
• Reducing Radiation Exposure
• Reducing Shoulder Pain
• Improving Spinal Surgery Outcomes
• Cone-Beam Computed Tomography
• Greater Use of Needle Biopsies
• MIS Lateral Approach Platform
• Image and Robotic Guidance
• MR-Guided Ultrasound

Tuesday, 16 August 2011

Out of Pocket Healthcare Spending 2011

Published: April 2011
No. of Pages: 85
Price: $ 1995

The costs of health care products and services continue to rise briskly, significantly outpacing currently low inflation rates. According to the U.S. Department of Labor, the average household's spending on health care after inflation has been rising by about 1.4% each year. Retirees have been particularly hard hit, with inflation-adjusted out-of-pocket costs rising by more than 2% each year as a result of increased spending on prescription drugs.

While insurance is the most common form of payment for healthcare services, increasingly customers are paying for their own expenses. Pharmaceutical, device and diagnostic companies, should recognize that a part of their revenues are originating directly or indirectly from out of pocket expenditures. Unique financial services have been created to facilitate non-insurance-paid health care services, and more are expected to be created in the near term.

This report, Out of Pocket Healthcare Spending 2011 focuses on those costs of health care which are not paid for by government or private insurance. Once a small percentage of costs of the health care system, the percentage borne by the consumer is increasing steadily. Included in the report is:
• Estimates of the Current 'Out of Pocket' Healthcare Spending Market and Forecasts to 2015.
• Breakdown of Spending by Type (Elective, Hospital, Emergency Room, Dental, Vision Outpatient, Prescription Drugs, Office Based Visit, Other)
• Health Care Reform and Its Impact on Out of Pocket Spending
• Statistics For the Types of Consumers Most Likely to Pay Out of Pocket
• Drivers of the Out of Pocket Trend and Potential Limiters
• Overview of the U.S. Healthcare System, Insured and Uninsured Population.
• The Types of Services and Products Purchased with Out of Pocket dollars
• Overview of the growing Healthcare Finance market and a look at key competitors.
The economic recession of December 2007 to October 2009 represented a major downturn that led to broad-based cost-cutting, rising unemployment and reduced disposable income. The impact of the pullback - which some experts compared to the Great Depression of 1929 to 1934 - cannot be overstated. Kalorama Information looks at what change has resulted in out of pocket expenditure for healthcare as a result of the recession and weak recovery.

As part of Kalorama Information's trusted process, secondary research from government, medical and industry sources was utilized along with interviews with industry experts in the healthcare finance industry.

In Weak Recovery, Consumers Bearing More of Healthcare Costs

Healthcare costs paid out-of-pocket by consumers have increased steadily in recent years, but according to Kalorama Information, the recession and weak recovery are additional drivers for the trend. In fact, the independent healthcare market research firm has found in its new report, Out of Pocket Healthcare Spending 2011, that out-of-pocket healthcare spending was $303 billion in 2010 and the rate of growth will accelerate at 8% annually in the coming years.

According to the U.S. Department of Labor, the average household's inflation-adjusted spending on healthcare has been rising by about 1.4% each year. Retirees have been particularly hard hit, with inflation-adjusted out-of-pocket healthcare costs rising by more than 2% each year as a result of increased spending on prescription drugs.

"The recent recession brought with it a high unemployment rate, exacerbated by increased outsourcing of jobs to lower cost countries, broad-based cost-cutting and reduced disposable income," said Bruce Carlson, publisher of Kalorama Information. "Meanwhile, affordable healthcare has become less available but more necessary."

The costs of healthcare products and services continue to rise briskly; in some cases, they have become astronomical. For example, in 2010, average annual healthcare premiums for a family of four ($13,770) approached annual earnings at the federal minimum wage ($14,500). As a result, Kalorama notes that managed care organizations are increasingly shifting the burden of healthcare costs to consumers by way of increased co-pays and premiums.

About 70% of consumers' out-of-pocket healthcare spending goes to premiums. And this is increasing as HMOs and employers engage in cost shifting. Co-pays make up a little over 3% of spending, which Kalorama also expects to increase due to cost shifting. Another 27% of out-of-pocket spending goes to direct payments.

The Health Care Reform of 2010 has significantly changed the landscape of the U.S. healthcare industry by extending healthcare coverage to approximately 32 million previously uninsured people. Although this could potentially decrease some demand for out-of-pocket spending from the previously uninsured, it may in fact, raise awareness of the value of basic care and bring more persons into the medical system, thus potentially increasing spending as newly insured consumers take a renewed interest in their health and wellness.

Tuesday, 9 August 2011

Minimally Invasive Surgical Devices, World Market

Published: May 2011
No. of Pages:150
Price: $ 3500

Minimally invasive surgery (MIS) allows doctors to perform many complicated operations with a short hospital stay. It is a safe, feasible, and patient-friendly method of performing an operation. The report includes product information, procedure volume data, world demographics; and other general issues affecting the Minimally Invasive Surgical devices market. Information is presented as a worldwide overview, with a focus on the US. A market summary includes market analysis by intended use and a competitive analysis of leading providers. Additionally key company profiles are included.

Browse All: Healthcare Market Research

The report provides total market sizes in six general surgery areas reflecting revenues earned by all manufacturers in all MIS methods in those areas. Revenues for each therapeutic area. were gathered through both primary and secondary research methods. General surgery areas include:
• Orthopedic MIS Device Market (included in total market size number in this report are arthoscopes, autoclavable laoparoscope, holmium lasers, other devices)
• Neurosurgery MIS Device Market (included in total market size number in this report are neuroendoscopes, bronchoscope, esophoscope, others)
• ENT/Respiratory MIS Device Market (included in total market size number in this report are laryngoscopes, ventriculoscopes, contact lasers, others)
• Cardiovascular MIS Device Market (included in total market size figure are laparoscopes, ablation systems, endoscopes, others)
• Gastrointestinal System MIS Device Market (included in total market size figure are endoscopes, sigmoidoscopes, videoscopes, others)
• Urological and Gynecological MIS Device Market (included in total market size figure are hysteroscopes, cystoscopes, others)
The purpose of this report is to provide understanding of the total current market for all MIS methods for each therapeutic area. In the scope of this report they are considered as competitive methods and are not broken down to specific device segments (for instance 'Gastroinestinal System Devices' will contain a number for all competiting MIS methods in GI, but will not have a specific sigmoidoscope or GI endoscope number.)

Five year forecasts are also provided. As this is a global survey, Revenues are provided for the following regions:
• US
• Europe
• Rest of World

Procedure volumes are available for the following surgeries for which minimally invasive equipment is utilized:
• Hip Replacement, Pinning, etc.
• Knee Repair/Fixation, Procedures
• Spinal Fusion/Spinal Hardware Removal
• Shoulder Repair/Fixation
• Lumbar Laminectomy/ Thoracic-lumbar
• Laminectomy/Diskectomy and Lumbar Decompression and Fusion
• Craniotomy (all types)
• Ventricular-Peritoneal Shunt Insertion/ Removal/Revision
• Detether Cord (adult and pediatric)
• Ethmoidectomy
• Tonsillectomy
• Thyroidectomy
• Coronary Revascularization
• Aortic Valve Replacement or Repair
• Cardiac Catheterization
• Insertion of Coronary Artery Stent(s)
• Appendectomy
• Endoscopy with or without biopsy
• Cholecystectomy
• Inguinal Herniorrhaphy
• Hysterectomy (all types)
• Prostatectomy

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 45 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives:
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2010. Compound annual growth rates (CAGRs) are provided for each region and/or segment covered. Competitive analysis is provided for the year 2010. The forecasted market analysis for was largely based on demographic trends, new developments, and global expansion.